breckenridge pharmaceutical propranolol recall: trending now
17-11-2026
Breckenridge Pharmaceutical Propranolol Recall: What Patients Need to Know Right Now
The Breckenridge Pharmaceutical propranolol recall is trending across health and pharmaceutical news following a nationwide consumer-level alert issued on November 16, 2026. Breckenridge Pharmaceutical, Inc. voluntarily recalled one specific lot of its 60 mg Propranolol Hydrochloride Extended-Release Capsules, USP, manufactured by Adare Pharma Solutions, due to potential metal contamination.
Breckenridge Pharmaceutical, IncWhy Is Breckenridge Pharmaceutical Recalling Propranolol?
The voluntary nationwide recall was initiated after investigators discovered that the affected batch shared an intermediate material suspected of causing metal contamination in a separate, unreleased lot. According to the official recall notice conducted with the knowledge of the U.S. Food and Drug Administration (FDA), ingesting metal fragments from the contaminated capsules could cause soft-tissue lacerations in the mouth, esophagus, stomach, or intestines. While no adverse health events have been reported to date, the propranolol recall was elevated to the consumer level out of an abundance of caution.
PR Newswire+ 1How to Identify the Recalled Propranolol Lot
This blood pressure medication recall applies strictly to one lot distributed nationwide to wholesalers and pharmacies between October 26, 2026, and November 4, 2026. Other strengths, immediate-release tablets, and different lot numbers are not impacted. Patients and pharmacists can verify their prescription bottles using the following identifiers:
NacionaleProduct Name: Propranolol Hydrochloride Extended-Release Capsules, USP (60 mg)
PR NewswirePackage Size: 100-count bottle
National Drug Code (NDC): 51991-817-01
Lot Number: PK25110035
Expiration Date: May 2029
PR Newswire
Immediate Steps for Patients and Pharmacies
Propranolol is a widely prescribed beta-blocker used to treat high blood pressure (hypertension), chest pain (angina), tremors, and migraines. Because abruptly stopping a beta-blocker can trigger serious cardiovascular complications, patients should follow official safety guidance carefully:
Geo News+ 1Check Your Prescription Label: Verify the NDC and lot number on your medication bottle or contact your dispensing pharmacy if the manufacturer details are not visible.
NacionaleContact Your Healthcare Provider: Stop taking capsules from the recalled lot and immediately reach out to your doctor or pharmacist for a safe replacement and medical advice before altering your treatment regimen.
PR Newswire